News

Despite the increase in the number of human infections with avian influenza A (H7N9) virus during the fifth epidemic in China, a new study suggests no change in the risk of transmission of the virus among humans over time.

Predicting the next infectious disease outbreak may be possible by analyzing trends on Twitter and Google.

Does following the NSQIP reduce post-operative UTIs?

However, findings from the study may provide a roadmap for future analyses of immune-based interventions seeking to relieve HIV patients of the lifelong burden of daily medication intake and enhance viral suppression.

Researchers have developed a new material for use in dental procedures that uses an antimicrobial agent to fight off bacteria and prevent plaque buildup.

Single-dose tinidazole is the best available treatment for giardiasis in children and adults, a new study shows.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

As the population of people living with HIV infection is living longer, age-related health issues are affecting these individuals in an accelerated or emphasized fashion.

A pair of studies recently conducted as part of the Human Vaccines Project are giving new insight into the human immune system and how researchers can develop better vaccines.

More than 110 suspected cases have already been reported, including 6 deaths.

Investigators are finding that a 4-days-a-week regimen of antiretroviral therapy (ART) may be as safe and effective as daily therapy in treating HIV, while keeping costs down and lowering risks of side effects.

Here are a few things your friendly infection control team would appreciate for the holidays.

The US Food and Drug Administration (FDA) has approved a rapid diagnostic test for Valley Fever.

Experts from academia, industry, and public health agencies—including the Centers for Disease Control and Prevention and the US Food and Drug Administration—discuss the new generation of antibody tests.

After 2 years, the risk for these men dropped only slightly, making them 14 times more likely to be reinfected.

Following a severe flu season in the Southern Hemisphere and mounting research that egg-based flu vaccines don’t offer enough protection, experts are warning that the Northern Hemisphere may be in for a tough flu season.

Questions regarding a finance executive’s expertise in infectious diseases aside, the move seems straightforward enough—at least on the surface.

Researchers from Harvard Medical School conducted one of the largest studies to date to examine the impact of pneumococcal vaccines and antibiotic usage on trends in colonization in young, healthy children.

We break down the Top 5 infectious disease news reported by Contagion® for the month of November 2017.

A new study examines HCV treatment uptake in HCV patients coinfected with HIV.

A team of investigators explores if fecal microbiota transplant (FMT) capsules are just as effective as treatment via colonoscopy.

The results of 3 phase 1 clinical trials have shown that an investigational Zika purified inactivated virus vaccine was well-tolerated and induced an immune response in adult participants.

On National Cookie Day, it’s important to remember to avoid consuming any raw baking materials or you'll run the risk of infection.

A new announcement marks the elimination of mother-to-child HIV transmission in 6 Caribbean territories and states

The Society for Healthcare Epidemiology of America (SHEA), with support from the Centers for Disease Control and Prevention (CDC), released new expert guidance to help hospitals prepare for and contain infectious disease outbreaks.

This approach could significantly cut down on the cost and time needed to develop new antibiotics, which is critical considering the current antibiotic landscape.

Stay up-to-date on the latest infectious disease news by checking out our top 5 articles of the week.

The National Institutes of Health (NIH) have announced plans for a new trial testing the effectiveness of the injectable pre-exposure prophylaxis (PrEP) drug, cabotegravir, in sexually-active women.